全氟丁烷增强超声联合库普弗期:提高肝细胞癌诊断敏感度
该回顾性多中心研究纳入123例高危患者的123个肝结节,评估全氟丁烷增强超声对肝细胞癌的诊断准确性。以动脉期高增强联合库普弗期缺损(AK标准)诊断肝细胞癌的敏感度为83.1%,高于LI-RADS标准的75.3%(p=0.041),两者特异度均为91.3%。结合灰度超声边界不清且无低回声晕的调整可减少假阳性。
要点
- 全氟丁烷增强超声中,库普弗期缺损替代晚/轻度廓清可提高肝细胞癌诊断敏感度。
- AK标准敏感度83.1%,高于LI-RADS标准的75.3%,特异度均为91.3%。
- 灰度超声边界不清且无低回声晕的病灶不提示肝细胞癌,据此调整可减少假阳性。
核心结论
- 全氟丁烷增强超声使用库普弗期缺损并结合灰度超声表现调整的诊断标准,对肝细胞癌的诊断效能高于传统LI-RADS标准,且未降低特异度。
研究设计与样本
- 回顾性分析2013至2020年三家机构123例高危患者的123个肝结节(≥1 cm),93%的受试者有病理结果(良性病变随访影像稳定者除外),评估动脉期高增强、廓清时间与程度及库普弗期缺损,采用McNemar检验比较诊断效能。
关键影像表现/征象
- 库普弗期缺损定义为库普弗期病灶相对于肝脏呈低增强。
- 灰度超声上边界不清且无低回声晕的征象不提示肝细胞癌。
诊断标准与关键数值
- LI-RADS标准:动脉期高增强及晚(≥60秒)/轻度廓清,诊断肝细胞癌敏感度75.3%(95%CI:64.2-84.4%),特异度91.3%(95%CI:79.2-97.6%)。
- AK标准:动脉期高增强及库普弗期缺损,诊断肝细胞癌敏感度83.1%(95%CI:72.9-90.7%),特异度91.3%(95%CI:79.2-97.6%)。
- AK标准敏感度高于LI-RADS标准(p=0.041),两者特异度均为91.3%。
临床应用与阅片要点
- 采用库普弗期缺损替代晚/轻度廓清并结合灰度超声边界不清且无低回声晕的调整,可提高全氟丁烷增强超声对肝细胞癌的诊断效能。
- 结合灰度超声表现调整后,AK标准的敏感度和准确率均高于LI-RADS标准,两者特异度均为91.3%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the diagnostic accuracy of perfluorobutane contrast-enhanced ultrasonography (CEUS) for hepatocellular carcinoma (HCC) and to explore how accuracy can be improved compared to conventional diagnostic criteria in at-risk patients.
METHODS: A total of 123 hepatic nodules (≥ 1 cm) from 123 at-risk patients who underwent perfluorobutane CEUS between 2013 and 2020 at three institutions were retrospectively analyzed. Ninety-three percent of subjects had pathological results, except benign lesions stable in follow-up images. We evaluated presence of arterial phase hyperenhancement (APHE), washout time and degree, and Kupffer phase (KP) defects. KP defects are defined as hypoenhancing lesions relative to the liver in KP. HCC was diagnosed in two ways: (1) Liver Imaging Reporting and Data System (LI-RADS) criteria defined as APHE and late (≥ 60 s)/mild washout, and (2) APHE and Kupffer (AK) criteria defined as APHE and KP defect. We explored grayscale features that cause misdiagnosis of HCC and reflected in the adjustment. Diagnostic performance was compared using McNemar's test.
RESULTS: There were 77 HCCs, 15 non-HCC malignancies, and 31 benign lesions. An ill-defined margin without hypoechoic halo on grayscale applied as a finding that did not suggest HCC. Regarding diagnosis of HCC, sensitivity of AK criteria (83.1%; 95% confidence interval [CI]: 72.9-90.7%) was higher than that of LI-RADS criteria (75.3%; 95% CI: 64.2-84.4%; p = 0.041). Specificity was 91.3% (95% CI: 79.2-97.6%) in both groups.
CONCLUSION: On perfluorobutane CEUS, diagnostic criteria for HCC using KP defect with adjustment by grayscale findings had higher diagnostic performance than conventional criteria without losing specificity.
KEY POINTS: • Applying Kupffer phase defect instead of late/mild washout and adjusting with grayscale findings can improve the diagnostic performance of perfluorobutane-enhanced US for HCC. • Adjustment with ill-defined margins without a hypoechoic halo for features unlikely to be HCC decreases false positives for HCC diagnosis using the perfluorobutane-enhanced US. • After adjustment with grayscale findings, the sensitivity and accuracy of the APHE and Kupffer criteria were higher than those of the LI-RADS criteria; specificity was 91.3% for both.
引用
- Hwang, Jeong, Kang, et al. Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma. Eur Radiol. 2022. PMID: 35705829. doi:10.1007/s00330-022-08900-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。